特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
952883

プロテオミクス市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2020~2025年)

Proteomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 119 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
プロテオミクス市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2020~2025年)
出版日: 2020年07月18日
発行: IMARC Services Private Limited
ページ情報: 英文 119 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプロテオミクス市場は、2014~2019年に約15%のCAGRで成長を遂げました。市場成長の主な要因として、創薬・バイオテクノロジー分野での研究開発 (R&D) 活動の活発化や、オーダーメイド医薬品の人気拡大、バイオマーカー分析技術の進歩などが挙げられます。

当レポートでは、世界のプロテオミクス市場の構造と動向について分析し、市場の全体的構造や、市場規模の推移・予測 (過去・今後6年間分)、分析の種類別・コンポーネントの種類別・技術別・用途別・エンドユーザー別・地域別の詳細動向、市場の求心力・競争情勢、主要企業のプロファイルなどについて調査しております。

目次

第1章 序論

第2章 分析範囲・手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のプロテオミクス市場

  • 市場概要
  • 市場規模の実績値

第6章 分析の種類別の市場区分

  • 構造プロテオミクス
  • 機能プロテオミクス
  • タンパク質発現プロテオミクス

第7章 コンポーネントの種類別の市場区分

  • コア・プロテオミクス・サービス
  • バイオインフォマティクス・ソフトウェアと関連サービス

第8章 技術別の市場区分

  • 分光法
  • クロマトグラフィー
  • 電気泳動
  • タンパク質マイクロアレイ
  • X線結晶学
  • 表面プラズモン共鳴
  • その他

第9章 用途別の市場区分

  • タンパク質発現プロファイリング
  • プロテオームマイニング
  • 翻訳後修飾

第10章 エンドユーザー別の市場区分

  • 臨床診断検査室
  • 研究機関 (創薬)
  • その他

第11章 地域別の市場区分

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東とアフリカ
    • 市場分析:国別

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Bio-RAD Laboratories Inc.
    • Bruker Corporation
    • Creative Proteomics
    • Danaher Corporation
    • GE Healthcare Inc.
    • 堀場製作所
    • Luminex Corporation
    • Merck Group
    • Perkinelmer Inc.
    • Promega Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Proteomics Market: Major Drivers and Challenges
  • Figure 2: Global: Proteomics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Proteomics Market: Breakup by Analysis Type (in %), 2019
  • Figure 4: Global: Proteomics Market: Breakup by Component Type (in %), 2019
  • Figure 5: Global: Proteomics Market: Breakup by Technology (in %), 2019
  • Figure 6: Global: Proteomics Market: Breakup by Application (in %), 2019
  • Figure 7: Global: Proteomics Market: Breakup by End-User (in %), 2019
  • Figure 8: Global: Proteomics Market: Breakup by Region (in %), 2019
  • Figure 9: Global: Proteomics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 10: Global: Proteomics (Structural Proteomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Proteomics (Structural Proteomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Proteomics (Functional Proteomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Proteomics (Functional Proteomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Proteomics (Protein Expression Proteomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Proteomics (Protein Expression Proteomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Proteomics (Core Proteomics Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Proteomics (Core Proteomics Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Proteomics (Bioinformatics Software and Related Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Proteomics (Bioinformatics Software and Related Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Proteomics (Spectroscopy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Proteomics (Spectroscopy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Proteomics (Chromatography) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Proteomics (Chromatography) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Proteomics (Electrophoresis) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Proteomics (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Proteomics (Protein Microarrays) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Proteomics (Protein Microarrays) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Proteomics (X-Ray Crystallography) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Proteomics (X-Ray Crystallography) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: Global: Proteomics (Surface Plasmon Resonance) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: Global: Proteomics (Surface Plasmon Resonance) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: Global: Proteomics (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: Global: Proteomics (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Global: Proteomics (Protein Expression Profiling) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Global: Proteomics (Protein Expression Profiling) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: Global: Proteomics (Proteome Mining) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: Global: Proteomics (Proteome Mining) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: Global: Proteomics (Post-translational Modifications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: Global: Proteomics (Post-translational Modifications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: Global: Proteomics (Clinical Diagnostic Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: Global: Proteomics (Clinical Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: Global: Proteomics (Research Organizations- Drug Discovery) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: Global: Proteomics (Research Organizations- Drug Discovery) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: Global: Proteomics (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: Global: Proteomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: North America: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: North America: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: United States: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: United States: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Canada: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Canada: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Asia Pacific: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Asia Pacific: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: China: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: China: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: Japan: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: Japan: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: India: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: India: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: South Korea: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: South Korea: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Australia: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Australia: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Indonesia: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Indonesia: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Others: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Europe: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Europe: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Germany: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Germany: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: France: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: France: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: United Kingdom: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: United Kingdom: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Italy: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 77: Italy: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 78: Spain: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 79: Spain: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 80: Russia: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 81: Russia: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 82: Others: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 83: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 84: Latin America: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 85: Latin America: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 86: Brazil: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 87: Brazil: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 88: Mexico: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 89: Mexico: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 90: Others: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 91: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 92: Middle East and Africa: Proteomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 93: Middle East and Africa: Proteomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 94: Global: Proteomics Industry: SWOT Analysis
  • Figure 95: Global: Proteomics Industry: Value Chain Analysis
  • Figure 96: Global: Proteomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Proteomics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Proteomics Market Forecast: Breakup by Analysis Type (in Million US$), 2020-2025
  • Table 3: Global: Proteomics Market Forecast: Breakup by Component Type (in Million US$), 2020-2025
  • Table 4: Global: Proteomics Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 5: Global: Proteomics Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 6: Global: Proteomics Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 7: Global: Proteomics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 8: Global: Proteomics Market Structure
  • Table 9: Global: Proteomics Market: Key Players
目次
Product Code: SR1019K17_Report

The global proteomics market grew at a CAGR of around 15% during 2014-2019. Proteomics refers to the study of proteomes, their structure and physiological functions on a large-scale. In 1994, Mark Wilkins first coined the term proteome for the proteins that are translated from genome, to denote the whole set of proteins synthesized within a living organism. It encompasses the modifications and alterations that take place in the existing protein when it is exposed to varying conditions. Proteomics applies various technologies for the quantification and identification of proteins, along with the detection of diagnostic markers, understanding of pathogens in cells and interpretation of protein pathways in different diseases. It also evaluates the rate of protein production and the interaction patterns of proteins due to which it finds extensive applicability in drug discovery and the development of personalized medications.

The growing preference for personalized drugs, along with increasing research and development in drug discovery and biotechnology, is the key factor driving the growth of the market. Proteomic systems reduce the time, cost and resources needed for the chemical synthesis and biological testing of drugs and simplify the process of drug discovery. Furthermore, opportunities related to biomarker identification and mass spectrometry-based proteomics are favoring the market growth further. Additionally, the market is driven by increasing technological penetration in the comprehensive analysis of protein techniques. These techniques include Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems and X-ray crystallography. These advancements enable a thorough quantitative and qualitative analysis of proteins and identification of cancer therapies and treatments. Other factors, such as favorable government policies for extensive research and development (R&D) are also augmenting the growth of the market. Looking forward, IMARC Group expects the market to continue its strong growth during the next five years.

Breakup by Analysis Type:

  • Structural Proteomics
  • Functional Proteomics
  • Protein Expression Proteomics

Breakup by Component Type:

  • Core Proteomics Services
  • Bioinformatics Software and Related Services

Breakup by Technology:

  • Spectroscopy
  • Chromatography
  • Electrophoresis
  • Protein Microarrays
  • X-Ray Crystallography
  • Surface Plasmon Resonance
  • Others

Breakup by Application:

  • Protein Expression Profiling
  • Proteome Mining
  • Post-translational Modifications

Breakup by End-User:

  • Clinical Diagnostic Laboratories
  • Research Organizations (Drug Discovery)
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report:

  • How has the global proteomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the analysis type?
  • What is the breakup of the market based on the component type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the services and software?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global proteomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Proteomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Analysis Type

  • 6.1 Structural Proteomics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Functional Proteomics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Protein Expression Proteomics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Component Type

  • 7.1 Core Proteomics Services
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics Software and Related Services
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Technology

  • 7.1 Spectroscopy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chromatography
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Electrophoresis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Protein Microarrays
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 X-Ray Crystallography
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Surface Plasmon Resonance
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Protein Expression Profiling
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Proteome Mining
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Post-translational Modifications
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Clinical Diagnostic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Organizations (Drug Discovery)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.2 Others
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-RAD Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bruker Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Creative Proteomics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GE Healthcare Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Horiba Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Luminex Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Merck Group
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Perkinelmer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Promega Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Waters Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.